Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001104659-22-063496
Filing Date
2022-05-20
Accepted
2022-05-20 17:22:13
Documents
10

Document Format Files

Seq Description Document Type Size
1 F-3 tm2216043-1_f3.htm F-3 485318
2 EXHIBIT 5.1 tm2216043d2_ex5-1.htm EX-5.1 27964
3 EXHIBIT 23.1 tm2216043d2_ex23-1.htm EX-23.1 1616
4 EX-FILING FEES tm2216043d2_ex107.htm EX-FILING FEES 43359
5 GRAPHIC lg_evaxion-4c.jpg GRAPHIC 28095
6 GRAPHIC tm2216043d2_ex5-1img0001.jpg GRAPHIC 3034
7 GRAPHIC tm2216043d2_ex5-1img0002.jpg GRAPHIC 3070
8 GRAPHIC tm2216043d2_ex5-1img0003.jpg GRAPHIC 3070
9 GRAPHIC tm2216043d2_ex5-1img0004.jpg GRAPHIC 3070
10 GRAPHIC tm2216043d2_ex5-1img0005.jpg GRAPHIC 3070
  Complete submission text file 0001104659-22-063496.txt   619985
Mailing Address BREDGADE 34E COPENHAGEN K G7 1260
Business Address BREDGADE 34E COPENHAGEN K G7 1260 4531262615
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-265132 | Film No.: 22948852
SIC: 2836 Biological Products, (No Diagnostic Substances)